ArticleTheranostics2020
PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.
Qiming Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleTheranostics2020
Qiming Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.